selected publications
-
academic article
-
Waibel MVervoort SJKong IYHeinzel SRamsbottom KMMartin BPHawkins EDJohnstone RW. Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.
Leukemia.
32:237-241.
2018
Full text if available -
Horton MBPrevedello GMarchingo JMZhou JHSDuffy KRHeinzel SHodgkin PD. Multiplexed Division Tracking Dyes for Proliferation-Based Clonal Lineage Tracing.
Journal of Immunology.
201:1097-1103.
2018
Full text if available -
Dowling MRKan AHeinzel SMarchingo JMHodgkin PDHawkins ED. Regulatory T Cells Suppress Effector T Cell Proliferation by Limiting Division Destiny.
Frontiers in Immunology.
9:1-10.
2018
Full text if available -
Heinzel SMarchingo JMHorton MBHodgkin PD. The regulation of lymphocyte activation and proliferation.
Current Opinion in Immunology.
51:32-38.
2018
Full text if available -
Heinzel SBinh Giang TKan AMarchingo JMLye BKCorcoran LMHodgkin PD. A Myc-dependent division timer complements a cell-death timer to regulate T cell and B cell responses.
Nature Immunology.
18:96-103.
2017
Full text if available -
Schenk RLTuzlak SCarrington EMZhan YHeinzel STeh CEGray DHTai LLew AMVillunger AStrasser AHerold MJ. Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment.
Cell Death and Differentiation.
24:534-545.
2017
Full text if available -
Sutherland RMLondrigan SLBrady JLCarrington EMMarchingo JMHeinzel SHodgkin PDGraham KLKay TWZhan YLew AM. Cognate antigen engagement on parenchymal cells stimulates CD8+ T cell proliferation in situ.
Nature Communications.
8:1-10.
2017
Full text if available -
Zhan YCarrington EMZhang YHeinzel SLew AM. Life and Death of Activated T Cells: How Are They Different from Naïve T Cells?.
Frontiers in Immunology.
8.
2017
Full text if available -
Kan APavlyshyn DMarkham JFDowling MRHeinzel SZhou JHSMarchingo JMHodgkin PD. Stochastic measurement models for quantifying lymphocyte responses using flow cytometry.
PLoS ONE.
11:e0146227-e0146227.
2016
Full text if available -
Marchingo JMPrevedello GKan AHeinzel SHodgkin PDDuffy KR. T-cell stimuli independently sum to regulate an inherited clonal division fate.
Nature Communications.
7.
2016
Full text if available -
Marchingo JMKan ASutherland RMDuffy KRWellard CJBelz GTLew AMDowling MRHeinzel SHodgkin PD. Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansion.
Science.
346:1123-1127.
2014
Full text if available -
Gordon DKelley PHeinzel SCooper PPetrovsky N. Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study.
Vaccine.
32:6469-6477.
2014
Full text if available -
Dowling MRKan AHeinzel SZhou JHSMarchingo JMWellard CJMarkham JFHodgkin PD. Stretched cell cycle model for proliferating lymphocytes.
Proceedings of the National Academy of Sciences of USA.
111:6377-6382.
2014
Full text if available -
Koenen PHeinzel SCarrington EMHappo LAlexander WSZhang J-GHerold MJScott CLLew AMStrasser AHodgkin PD. Mutually exclusive regulation of T cell survival by IL-7R and antigen receptor-induced signals.
Nature Communications.
4.
2013
Full text if available -
Gordon DLSajkov DWoodman RJHonda-Okubo YCox MMJHeinzel SPetrovsky N. Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant.
Vaccine.
30:5407-5416.
2012
Full text if available -
Suzuki HForrest ARRVan Nimwegen EDaub COBalwierz PJIrvine KMLassmann TRavasi THasegawa YDe Hoon MJLKatayama SSchroder KCarninci PTomaru YKanamori-Katayama MKubosaki AAkalin AAndo YArner EAsada MAsahara HBailey TBajic VBBauer DBeckhouse AGBertin NBjörkegren JBrombacher FBulger EChalk AMChiba JCloonan NDawe ADostie JEngström PGEssack MFaulkner GJFink JLFredman DFujimori KFuruno MGojobori TGough JGrimmond SMGustafsson MHashimoto MHashimoto THatakeyama MHeinzel SHide WHofmann OHörnquist MHuminiecki LIkeo KImamoto NInoue SInoue YIshihara RIwayanagi TJacobsen AKaur MKawaji HKerr MCKimura RKimura SKimura YKitano HKoga HKojima TKondo SKonno TKrogh AKruger AKumar ALenhard BLennartsson ALindow MLizio MMacPherson CMaeda NMaher CAMaqungo MMar JMatigian NAMatsuda HMattick JSMeier SMiyamoto SMiyamoto-Sato ENakabayashi KNakachi YNakano MNygaard SOkayama TOkazaki YOkuda-Yabukami HOrlando VOtomo JPachkov MPetrovsky N. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line.
Nature Genetics.
41:553-562.
2009
Full text if available -
Petrovsky NHeinzel SHonda YLyons AB. New-age vaccine adjuvants: Friend or foe?.
BioPharm International.
20:A24-A33.
2007
-
Petrovsky NHeinzel SHonda YLyons AB. New-age vaccine adjuvants: Friend or foe?.
BioPharm International.
20:24-33.
2007
-
Heinzel SMohty MOlive DGaugler B. Plasmacytoid DCs and cancer: a new role for an enigmatic cell.
Trends in Immunology.
25:397-398.
2004
Full text if available -
Coventry BHeinzel S. CD1a in human cancers: a new role for an old molecule.
Trends in Immunology.
25:242-248.
2004
Full text if available -
Heinzel SCappello F. Is CD1a involved in antitumour immune responses during carcinogenesis?.
British Journal of Cancer.
90:938-938.
2004
Full text if available -
Coventry BJHeinzel S. Reply: Is CD1a involved in antitumour immune responses during carcinogenesis?.
British Journal of Cancer.
90:939-939.
2004
Full text if available -
Sotiriadou RPerez SAGritzapis ADSotiropoulou PAEchner HHeinzel SMamalaki APawelec GVoelter WBaxevanis CNPapamichail M. Peptide HER2(776–788) represents a naturally processed broad MHC class II-restricted T cell epitope.
British Journal of Cancer.
85:1527-1534.
2001
Full text if available -
Heinzel SRea DOffringa RPawelec G. The self peptide annexin II (208-223) presented by dendritic cells sensitizes autologous CD4+ T lymphocytes to recognize melanoma cells.
Cancer Immunology Immunotherapy.
49:671-678.
2001
Full text if available -
Halder TMBlüggel MHeinzel SPawelec GMeyer HEKalbacher H. Defensins are dominant HLA-DR-associated self-peptides from CD34-peripheral blood mononuclear cells of different tumor patients (plasmacytoma, chronic myeloid leukemia).
Blood.
95:2890-2896.
2000
-
Pawelec GHeinzel SKiessling RMuller LOuyang QZeuthen J. Escape mechanisms in tumor immunity: A year 2000 update.
Critical Reviews in Oncogenesis.
11:97-133.
2000
-
Li KAdibzadeh MHalder TKalbacher HHeinzel SMüller CZeuthen JPawelec G. Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells.
Cancer Immunology Immunotherapy.
47:32-38.
1998
Full text if available
-
Waibel MVervoort SJKong IYHeinzel SRamsbottom KMMartin BPHawkins EDJohnstone RW. Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.
Leukemia.
32:237-241.
2018
-
conference paper
-
Liebregts TAdam BBredack CRöth AHeinzel SLester SDownie–Doyle SSmith EDrew PTalley NJHoltmann G. Immune Activation in Patients With Irritable Bowel Syndrome.
Gastroenterology.
913-920.
2007
Full text if available -
Heinzel SHwang VCoventry BJ. Challenging the validity of CD1a as a marker of immature dendritic calls.
Tissue Antigens: immune response genetics.
440-440.
2005
-
Liebregts TAdam BBredack CRöth AHeinzel SLester SDownie–Doyle SSmith EDrew PTalley NJHoltmann G. Immune Activation in Patients With Irritable Bowel Syndrome.
Gastroenterology.
913-920.
2007
-
editorial article
-
Kurts CGottschalk CBedoui SHeinzel SGodfrey DEnders A. German Society for Immunology and Australasian Society for Immunology joint Workshop 3rd
-4th
December 2015 - Meeting report.
European Journal of Immunology.
46:265-268.
2016
Full text if available
-
Kurts CGottschalk CBedoui SHeinzel SGodfrey DEnders A. German Society for Immunology and Australasian Society for Immunology joint Workshop 3rd
-4th
December 2015 - Meeting report.
European Journal of Immunology.
46:265-268.
2016